Logiscreen

MoonLake Immunotherapeutics - Class A

$12.51
Market Cap 920.93M
ROE -83.2%
Gross Margin 0.0%
Debt/Equity 0.2
Current Ratio 12.6
Revenue QoQ 0.0%
EPS QoQ -0.0%
F-Score 3

About

Helix Acquisition Corp - Class A

Exchange
NASDAQ
Sector
Technology
Industry
Software - Application

Sector context

Technology

Undervalued

Trading at a discount to sector peers

P/E
-5.63
vs median 28.26
P/B
5.75
vs median 2.79
ROE
-0.86
vs median 0.18

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

WYFIARDTLSPDWLTHWBTNCXM
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics